Table 1.
Clinical characteristics of consenting patients.
| Variable | N = 25 |
|---|---|
| Age, Mean (SD) | 69.1 (6.6) |
| Male, (%) | 14 (56.0) |
| Smoking History, (%) | |
| Never | 1 (4.0) |
| Current | 6 (24.0) |
| Former | 18 (72.0) |
| Pack Years, Mean (SD) | 40.2 (28.2) |
| Pulmonary Function, Mean (SD) | |
| FEV1 (L) | 2.2 (0.5) |
| FEV1 % | 81.0 (13.8) |
| DLCO % | 78.0 (13.1) |
| Comorbidities, % | |
| Hypertension | 12 (48.0) |
| COPD | 8 (32.0) |
| Diabetes | 2 (8.0) |
| Oral Steroids | 0 |
| Resection Type, (%) | |
| Wedge | 3 (12.0) |
| Segment | 1 (4.0) |
| Lobe | 21 (8.0) |
| Surgical Approach, (%) | |
| Minimally Invasive | 21 (84.0) |
| Open | 4 (16.0) |
| Tumor Histology, (%) | |
| Adenocarcinoma | 16 (64.0) |
| Squamous Cell | 5 (20.0) |
| Carcinoid | 2 (8.0) |
| Carcinosarcoma | 1 (4.0) |
| Granuloma | 1 (4.0) |
| Tumor Size, cm, Mean (SD) | 2.6 (1.0) |
| Pathologic Stage, (%) | |
| Benign (Granuloma) | 1 (4.0) |
| I | 14 (56.0) |
| II | 5 (20.0) |
| III | 5 (20.0) |
| Lymph Node Status, (%) | |
| Negative | 16 (64.0) |
| Positive | 9 (36.0) |